BR9910098A - Derivados de carbapenem, utilização dos mesmos e compostos intermediários dos mesmos - Google Patents

Derivados de carbapenem, utilização dos mesmos e compostos intermediários dos mesmos

Info

Publication number
BR9910098A
BR9910098A BR9910098-3A BR9910098A BR9910098A BR 9910098 A BR9910098 A BR 9910098A BR 9910098 A BR9910098 A BR 9910098A BR 9910098 A BR9910098 A BR 9910098A
Authority
BR
Brazil
Prior art keywords
same
carbapenem
derivatives
intermediate compounds
compound
Prior art date
Application number
BR9910098-3A
Other languages
English (en)
Inventor
Hiroshi Matsui
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10122499A external-priority patent/JP2000344772A/ja
Priority claimed from JP10203730A external-priority patent/JP2000344773A/ja
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of BR9910098A publication Critical patent/BR9910098A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE CARBAPENEM, UTILIZAçãO DOS MESMOS E COMPOSTOS INTERMEDIáRIOS DOS MESMOS"<D>. Um composto carbapenem da fórmula (I) em que R¹ é um modificador hidrolisável no corpo vivo, R² e R³ são iguais ou diferentes e cada um é uma alquila inferior, R é como definido no relatório. O composto carbapenem (I) da presente invenção é superior na absorção no trato digestivo quando da administração oral e mostra propriedade antibacteriana suficiente contra uma ampla faixa de espécies de bactérias. Conseq³entemente, o composto é extremamente útil para a profilaxia e tratamento de doenças infecciosas (particularmente infecção bacteriana).
BR9910098-3A 1998-05-01 1999-04-28 Derivados de carbapenem, utilização dos mesmos e compostos intermediários dos mesmos BR9910098A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10122499A JP2000344772A (ja) 1998-05-01 1998-05-01 カルバペネム誘導体、その用途およびその中間体化合物
JP10203730A JP2000344773A (ja) 1998-07-17 1998-07-17 カルバペネム誘導体、およびその用途並びにその中間体化合物
PCT/JP1999/002301 WO1999057121A1 (fr) 1998-05-01 1999-04-28 Derives de carbapenem, son utilisation et composes intermediaires a base de carbapenem

Publications (1)

Publication Number Publication Date
BR9910098A true BR9910098A (pt) 2000-12-26

Family

ID=26459604

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910098-3A BR9910098A (pt) 1998-05-01 1999-04-28 Derivados de carbapenem, utilização dos mesmos e compostos intermediários dos mesmos

Country Status (24)

Country Link
US (1) US6410525B1 (pt)
EP (1) EP1078927B1 (pt)
KR (1) KR100589030B1 (pt)
CN (1) CN1163494C (pt)
AR (1) AR018335A1 (pt)
AT (1) ATE337321T1 (pt)
AU (1) AU760386B2 (pt)
BG (1) BG105004A (pt)
BR (1) BR9910098A (pt)
CA (1) CA2330641A1 (pt)
CO (1) CO5011051A1 (pt)
CZ (1) CZ292623B6 (pt)
DE (1) DE69932927D1 (pt)
HU (1) HUP0101735A3 (pt)
ID (1) ID27081A (pt)
NO (1) NO20005480L (pt)
NZ (1) NZ508493A (pt)
PL (1) PL343728A1 (pt)
RU (1) RU2222540C2 (pt)
SK (1) SK16382000A3 (pt)
TR (1) TR200003199T2 (pt)
TW (1) TW528750B (pt)
WO (1) WO1999057121A1 (pt)
YU (1) YU66700A (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1620433A (zh) * 2000-07-19 2005-05-25 霍夫曼-拉罗奇有限公司 作为内皮肽转化酶抑制剂的吡咯烷衍生物
NZ530170A (en) * 2001-05-21 2005-09-30 Kyoto Pharma Ind Carbapenem compound
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
JP4377231B2 (ja) 2001-11-05 2009-12-02 大日本住友製薬株式会社 新規なカルバペネム化合物
EP1612211A4 (en) 2003-04-08 2008-07-02 Dainippon Sumitomo Pharma Co NEW CARBAPENEM COMPOUNDS
EP1785426A4 (en) * 2004-09-03 2008-02-20 Dainippon Sumitomo Pharma Co NEW CARBAPENEM DERIVATIVE
EP1864985A4 (en) * 2005-03-25 2010-01-06 Dainippon Sumitomo Pharma Co NEW CARBAPENEM COMPOUND
KR20080041722A (ko) * 2005-08-31 2008-05-13 와이어쓰 글리실사이클린의 9-아미노카르보닐 치환된 유도체
CN101376656A (zh) * 2007-08-30 2009-03-04 山东轩竹医药科技有限公司 培南衍生物
BR112015023621A8 (pt) 2013-03-15 2018-01-23 Kala Pharmaceuticals Inc derivados de meropenem e suas utilizações
JP7437847B2 (ja) * 2018-10-01 2024-02-26 アリクサ ファーマシューティカルズ、インコーポレイテッド レレバクタムの誘導体およびその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60233076A (ja) 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
JPS61275279A (ja) 1984-12-25 1986-12-05 Sankyo Co Ltd カルバペネム化合物
IE60588B1 (en) 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
EP0597821A1 (en) 1988-04-01 1994-05-18 Sankyo Company Limited 2-(Heterocyclylthio)carbapenem derivatives their preparation and their use as antibiotics
US5242914A (en) 1988-04-01 1993-09-07 Sankyo Company, Limited 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics
AU644008B2 (en) 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
US5712267A (en) 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
US5360798A (en) 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
ATE223411T1 (de) 1995-12-21 2002-09-15 Sankyo Co 1-methylcarbapenem-derivate

Also Published As

Publication number Publication date
HUP0101735A2 (hu) 2001-12-28
ATE337321T1 (de) 2006-09-15
BG105004A (en) 2001-08-31
WO1999057121A1 (fr) 1999-11-11
CA2330641A1 (en) 1999-11-11
HUP0101735A3 (en) 2002-02-28
CN1307578A (zh) 2001-08-08
SK16382000A3 (sk) 2001-05-10
EP1078927B1 (en) 2006-08-23
AR018335A1 (es) 2001-11-14
EP1078927A1 (en) 2001-02-28
CO5011051A1 (es) 2001-02-28
PL343728A1 (en) 2001-09-10
NO20005480D0 (no) 2000-10-31
US6410525B1 (en) 2002-06-25
KR100589030B1 (ko) 2006-06-13
EP1078927A4 (en) 2003-01-08
TW528750B (en) 2003-04-21
RU2222540C2 (ru) 2004-01-27
CZ20003954A3 (cs) 2001-04-11
KR20010043196A (ko) 2001-05-25
YU66700A (sh) 2003-01-31
CN1163494C (zh) 2004-08-25
ID27081A (id) 2001-02-22
NO20005480L (no) 2000-12-20
AU760386B2 (en) 2003-05-15
CZ292623B6 (cs) 2003-11-12
TR200003199T2 (tr) 2001-03-21
NZ508493A (en) 2002-06-28
AU3627299A (en) 1999-11-23
DE69932927D1 (de) 2006-10-05

Similar Documents

Publication Publication Date Title
BR9910098A (pt) Derivados de carbapenem, utilização dos mesmos e compostos intermediários dos mesmos
BR9812364A (pt) Composto, uso do mesmo, composição farmacêutica, derivado de amida, e, processo para a preparação de um derivado de amida ou de um sal farmaceuticamente aceitável ou éster clivável in vivo deste
BR0013667A (pt) Derivados de glucopiranosiloxipirazol, composições medicinais contendo os mesmos derivados e seus intermediários na produção dos mesmos
DE60017115D1 (de) Amid-derivate und deren medizinische verwendung
PT1235826E (pt) Acrilamidas de quinuclidina
IL106842A (en) Pharmaceutical compositions comprising il-4r or derivatives thereof for the treatment, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and fungal infections
BR9611400A (pt) &#34;agentes antimicobiano de benzoxazina&#34;.
ATE250054T1 (de) Oxazolidinone derivate und pharmazeutische zusammensetzungen
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
FI933681A0 (fi) Antimikrobiellt medel
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
BRPI0511107A (pt) tratamento ou prevenção de infecções virais respiratórias com compostos imunomoduladores
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
EE200200088A (et) Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks
BRPI0411245A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de vìrus oncogênicos e para tratamento ou profilaxia de condições ou distúrbios devidos a infecção por hpv
AU2979899A (en) Treatment of viral disease in swine
AU740327C (en) Carbapenem compounds, use thereof and intermediate compound therefor
MXPA03010607A (es) Compuesto de carbapenem.
ATE293961T1 (de) Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie
TR199801835A2 (xx) Antimikrobiyal kompozisyonlar.
DE69810474D1 (de) Medizinische zusammensetzungen gegen helicobacter pylori
ATE338545T1 (de) Polymaleinimid-verbindungen und ihre medizinische verwendung
AP1684A (en) Dithiocarbamate derivatives and their use as antibacterial agents.
TH52880A3 (pt)

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.